Correlation Between Acticor Biotech and Mauna Kea

Can any of the company-specific risk be diversified away by investing in both Acticor Biotech and Mauna Kea at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acticor Biotech and Mauna Kea into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Acticor Biotech SAS and Mauna Kea Technologies, you can compare the effects of market volatilities on Acticor Biotech and Mauna Kea and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acticor Biotech with a short position of Mauna Kea. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acticor Biotech and Mauna Kea.

Diversification Opportunities for Acticor Biotech and Mauna Kea

0.42

Correlation Coefficient

Acticor Biotech  Mauna Kea

Very weak diversification

The 3 months correlation between Acticor and Mauna is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding Acticor Biotech SAS and Mauna Kea Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mauna Kea Technologies and Acticor Biotech is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acticor Biotech SAS are associated (or correlated) with Mauna Kea. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mauna Kea Technologies has no effect on the direction of Acticor Biotech i.e., Acticor Biotech and Mauna Kea go up and down completely randomly.

Pair Corralation between Acticor Biotech and Mauna Kea

Assuming the 90 days trading horizon Acticor Biotech SAS is expected to generate 3.93 times more return on investment than Mauna Kea. However, Acticor Biotech is 3.93 times more volatile than Mauna Kea Technologies. It trades about 0.02 of its potential returns per unit of risk. Mauna Kea Technologies is currently generating about -0.27 per unit of risk. If you would invest  42.00  in Acticor Biotech SAS on September 12, 2024 and sell it today you would lose (17.00) from holding Acticor Biotech SAS or give up 40.48% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Acticor Biotech SAS  vs.  Mauna Kea Technologies

Acticor Biotech SAS

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Acticor Biotech SAS are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak basic indicators, Acticor Biotech reported solid returns over the last few months and may actually be approaching a breakup point.

Mauna Kea Technologies

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Mauna Kea Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Pair Trading with Acticor Biotech and Mauna Kea

The main advantage of trading using opposite Acticor Biotech and Mauna Kea positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acticor Biotech position performs unexpectedly, Mauna Kea can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mauna Kea will offset losses from the drop in Mauna Kea's long position.

The idea behind Acticor Biotech SAS and Mauna Kea Technologies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.